ANALYSIS OF PLASMA PHYSOSTIGMINE CONCENTRATIONS BY LIQUID-CHROMATOGRAPHY

[1] CHRISTENSON I, 1969, ACTA PHARM SUEC, V6, P287

[2] QUANTITATIVE-DETERMINATION OF THE CHOLINESTERASE INHIBITOR PHYSOSTIGMINE IN BRAIN-TISSUE SAMPLES USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 225 (02): : 381 - 386

[3] Ellis S, 1943, J PHARMACOL EXP THER, V79, P364

[4] QUANTITATIVE ASSAY OF PHYSOSTIGMINE IN HUMAN WHOLE-BLOOD [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) : 389 - 391

[5] DETERMINATION OF PILOCARPINE, PHYSOSTIGMINE, ITS DEGRADATION PRODUCT RUBRESERINE AND PRESERVATIVES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1980, 198 (04): : 529 - 533

[6] MARTINDALE, 1977, EXTRA PHARMACOPOEIA, pR27

[7] DETERMINATION OF PHYSOSTIGMINE BY THIN-LAYER CHROMATOGRAPHY AND ULTRAVIOLET SPECTROPHOTOMETRY [J]. JOURNAL OF CHROMATOGRAPHY, 1973, 87 (01): : 125 - 136

[8] ROGERS AR, 1973, PHARM J, V211, P353

[9] TAYLOR P, 1980, PHARMACOL BASIS THER, P108

[1] CHRISTENSON I, 1969, ACTA PHARM SUEC, V6, P287

[2] QUANTITATIVE-DETERMINATION OF THE CHOLINESTERASE INHIBITOR PHYSOSTIGMINE IN BRAIN-TISSUE SAMPLES USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 225 (02): : 381 - 386

[3] Ellis S, 1943, J PHARMACOL EXP THER, V79, P364

[4] QUANTITATIVE ASSAY OF PHYSOSTIGMINE IN HUMAN WHOLE-BLOOD [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) : 389 - 391

[5] DETERMINATION OF PILOCARPINE, PHYSOSTIGMINE, ITS DEGRADATION PRODUCT RUBRESERINE AND PRESERVATIVES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J]. JOURNAL OF CHROMATOGRAPHY, 1980, 198 (04): : 529 - 533

[6] MARTINDALE, 1977, EXTRA PHARMACOPOEIA, pR27

[7] DETERMINATION OF PHYSOSTIGMINE BY THIN-LAYER CHROMATOGRAPHY AND ULTRAVIOLET SPECTROPHOTOMETRY [J]. JOURNAL OF CHROMATOGRAPHY, 1973, 87 (01): : 125 - 136

[8] ROGERS AR, 1973, PHARM J, V211, P353

[9] TAYLOR P, 1980, PHARMACOL BASIS THER, P108